Pfizer – Recall of Relpax® (eletriptan)
August 14, 2019 - Pfizer announced a voluntary patient-level recall of two lots of Relpax (eletriptan) 40 mg tablets because these product lots may not meet Pfizer’s in-house microbiological specification for the potential presence of genus Pseudomonas and Burkholderia.
Top